- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CSL Ltd (CSL)
CSL Ltd stock price live, this page displays ASX CSL stock exchange data. View the CSL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CSL Ltd real time stock price chart below.
What Is the CSL Ltd Stock Price Today?
The CSL Ltd stock price today is 175.35.
What Is the Stock Symbol for CSL Ltd?
The stock symbol for CSL Ltd is "CSL."
What Stock Exchange Does CSL Ltd Trade On?
CSL Ltd is listed and trades on the Sydney stock exchange.
Is CSL Ltd a Good Stock to Buy?
Determining whether CSL Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSL quote. (ISIN: AU000000CSL8)
What Is the CSL Ltd Stock Price Today?
The CSL Ltd stock price today is 175.35.
What Is the Stock Symbol for CSL Ltd?
The stock symbol for CSL Ltd is "CSL."
What Stock Exchange Does CSL Ltd Trade On?
CSL Ltd is listed and trades on the Sydney stock exchange.
Is CSL Ltd a Good Stock to Buy?
Determining whether CSL Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSL quote. (ISIN: AU000000CSL8)
175.35
-2.89(-1.62%)
Closed·
Fair Value
An estimate of a CSL's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
174.67
179.98
52 wk Range
90.00
222.47
CSL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a CSL's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
174.67179.98
52 wk Range
90.00222.47
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.27%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.27%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CSL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a CSL's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
185.07
Upside
+5.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 4 consecutive years
Csl Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
Csl Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Csl Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Csl Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Csl Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
10 Buy
7 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 185.07
(+5.54% Upside)
CSL Ltd Earnings Call Summary for H2/2026
- CSL reported FY26 revenue of $15.8B (down 1%) and underlying NPAT-A of $3.1B (down 2%); statutory loss of $2.6B due to $6B in restructuring charges.
- Shares surged 16.4% to $156.68 as company guided FY27 NPAT growth of ~5% despite flat revenue; authorized new AUD 1.1B buyback program.
- CSL Behring expected to return to mid-single-digit growth on strong immunoglobulin demand; Vifor remains major drag with ~25% revenue decline forecast.
- Company targeting $220M incremental savings in FY27, rising to $550M by FY28; maintaining dividend at $2.92/share with strong $3.5B operating cash flow.
- Seqirus forecast for low-single-digit growth despite soft U.S. flu market; management emphasized plasma efficiency and portfolio simplification as key priorities.
Last Updated: 18/08/2026, 02:28
Read Full TranscriptEarnings
Latest Release
Aug 18, 2025
EPS / Forecast
2.04 / 2.70
Revenue / Forecast
7.08B / 10.2B
Compare CSL to Peers and Sector
Metrics to compare | CSL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.3x | 19.0x | −0.4x | |
PEG Ratio | 0.12 | −0.55 | 0.00 | |
Price/Book | 3.9x | 1.7x | 2.6x | |
Price / LTM Sales | 3.6x | 2.0x | 3.0x | |
Upside (Analyst Target) | 3.8% | 51.0% | 56.4% | |
Fair Value Upside | Unlock | 14.5% | 7.9% | Unlock |
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company’s therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery. The company was formerly known as Commonwealth Serum Laboratories Limited and later changed its name to CSL Limited in October 1991. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the CSL (CSL) Stock Price Today?
The CSL stock price today is 175.35 AUD.
What Stock Exchange Does CSL Trade On?
CSL is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for CSL?
The stock symbol for CSL is "CSL."
What Is the CSL Market Cap?
As of today, CSL market cap is 85.36B AUD.
What Is CSL's Earnings Per Share (TTM)?
The CSL EPS (TTM) is -5.35.
From a Technical Analysis Perspective, Is CSL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has CSL Stock Split?
CSL has split 1 times.
How Many Employees Does CSL Have?
CSL has 29000 employees.
What is the current trading status of CSL (CSL)?
As of Oct 02, 2026, CSL (CSL) is trading at a price of 175.35 AUD, with a previous close of 175.35 AUD. The stock has fluctuated within a day range of 174.67 AUD to 179.98 AUD, while its 52-week range spans from 90.00 AUD to 222.47 AUD.
What Is CSL (CSL) Price Target According to Analysts?
The average 12-month price target for CSL is 185.07 AUD, with a high estimate of 219.07124315 AUD and a low estimate of 151.51860398 AUD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +5.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.